Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

Chapuis, J, Hot, D, Hansmannel, F, Kerdraon, O, Ferreira, S, Hubans, C, Maurage, C A, Huot, L +20 more·2009·Molecular Psychiatry
DOI 10.1038/mp.2009.10

Cited by (201)

Items 101–200 of 201

  1. Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
    Diana Boraschi, Paola Italiani, Paola Migliorini, Paola Bossù · 2023 · Frontiers in Immunology
  2. Genetic association of TLR4/11367 polymorphism with late-onset Alzheimer's disease in a Han Chinese population
    Lizhu Wang, Jin‐Tai Yu, Dan Miao, Zhong‐Chen Wu, Yu Zong, Cheng-quan Wen, Lan Tan · 2011 · Brain Research
  3. Role of interleukin 33 in human immunopathology
    Grace Murphy, Damo Xu, Foo Yew Liew, Iain B. McInnes · 2009 · Annals of the Rheumatic Diseases
  4. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation
    Pio Conti, Gianpaolo Ronconi, D Lauritano, Filiberto Mastrangelo, Alessandro Caraffa, Carla Enrica Gallenga, Ilias Frydas, Spyridon K. Kritas, Francesco Carinci, Federico Gaudelli et al. · 2024 · International Journal of Molecular Sciences
  5. The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases
    Sherry Sin-Hang Yeung, Janice Yuen Shan Ho, Raymond Chuen‐Chung Chang · 2021 · Experimental & Molecular Medicine
  6. Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease
    Robert I. Richards, Sarah Anne Robertson, Daniel L. Kastner · 2018 · Human Molecular Genetics
  7. Open reading frames associated with cancer in the dark matter of the human genome.
    Ana Paula Delgado, Pamela Brandao, Maria Julia Chapado, Sheilin Hamid, Ramaswamy Narayanan · 2014 · PubMed
  8. Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease
    Tomone Nagae, Kiho Araki · 2016 · Journal of Clinical & Cellular Immunology
  9. Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia
    Salvina Maria de Campos-Carli, Aline Silva de Miranda, Ingrid Caroline Silva Dias, Amanda de Sousa Oliveira, Breno Fiúza Cruz, Érica Leandro Marciano Vieira, Natália Pessoa Rocha, Izabela Guimarães Barbosa, João Vinícius Salgado, Antônio Lúcio Teixeira · 2017 · Comprehensive Psychiatry
  10. Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
    Francesca La Rosa, Marina Saresella, Francesca Baglio, Federica Piancone, Ivana Marventano, Elena Calabrese, Raffaello Nemni, Enrico Ripamonti, Monia Cabinio, Mario Clerici · 2017 · Scientific Reports
  11. The role of interleukin-33 in pathogenesis of bronchial asthma. New experimental data
    Musa Rakhimovich Khaitov, А. Р. Гайсина, Igor P. Shilovskiy, Smirnov Vv, Galina Vladislavovna Ramenskaya, Alexandra A. Nikonova, Rakhim M. Khaitov · 2018 · Biochemistry (Moscow)
  12. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
    Sudhanshu P. Raikwar, Ramasamy Thangavel, Iuliia Dubova, Mohammad Ejaz Ahmed, Govindhasamy Pushpavathi Selvakumar, Duraisamy Kempuraj, Smita A. Zaheer, Shankar S. Iyer, Asgar Zaheer · 2018 · Journal of Alzheimer s Disease
  13. Serum interleukin‐33 as a novel marker for long‐term prognosis and recurrence in acute ischemic stroke patients
    Xianmei Li, Xiao‐yang Wang, Xiaowen Feng, Mengmeng Shao, Wen‐Fang Liu, Qinqin Ma, En‐Pei Wang, Jie Chen, Bei Shao · 2019 · Brain and Behavior
  14. Association of Genes on Chromosome 6, GRIK2, TMEM217 and TMEM63B (Linked to MRPL14) with Diabetic Retinopathy
    Hui-Ju Lin, Yu-Chuen Huang, Jane-Ming Lin, Jer-Yuarn Wu, Liuh-An Chen, Fuu‐Jen Tsai · 2012 · Ophthalmologica
  15. Association of interleukin-33 gene single nucleotide polymorphisms with ischemic stroke in north Chinese population
    Liang Guo, Xinghu Zhou, Xiaofan Guo, Xingang Zhang, Yingxian Sun · 2013 · BMC Medical Genetics
  16. Plasma levels of soluble ST 2, but not IL ‐33, correlate with the severity of alcoholic liver disease
    Zijian Sun, Binxia Chang, Ang Huang, Shuli Hao, Miaomiao Gao, Ying Hui Sun, Ming Shi, Lei Jin, Wei Zhang, Jun Zhao et al. · 2018 · Journal of Cellular and Molecular Medicine
  17. IL33 in rheumatoid arthritis: potential contribution to pathogenesis
    Rafaela Bicalho Viana Macedo, Adriana María Kakehasi, Marcus Vinícius Melo de Andrade · 2016 · Revista Brasileira de Reumatologia (English Edition)
  18. The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies
    Karahan, Hande, Smith, Daniel C., Kim, Byungwook, McCord, Brianne, Mantor, Jordan, John, Sutha K., Al-Amin, Md Mamun, Dabin, Luke C., Kim, Jungsu · 2023 · Frontiers in Immunology
  19. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice
    Laia Montoliu‐Gaya, Jofre Güell‐Bosch, Gisela Esquerda-Canals, Alejandro R. Roda, Gabriel Serra-Mir, Silvia Lope‐Piedrafita, José Luis Sánchez‐Quesada, Sandra Villegas · 2018 · Biochemical Pharmacology
  20. Parent-of-origin effects of FAS and PDLIM1 in attention-deficit/hyperactivity disorder.
    Ke-Sheng Wang, Xue-Feng Liu, Qun-Yuan Zhang, Nagesh Aragam, Yue Pan · 2012 · Journal of Psychiatry & Neuroscience
  21. Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology
    Shun‐Fat Lau, Amy K.Y. Fu, Nancy Y. Ip · 2023 · Journal of Neurochemistry
  22. Associations between Variants in IL-33/ST2 Signaling Pathway Genes and Coronary Heart Disease Risk
    Fangqin Wu, Meian He, Qiang Wen, Wen Cai Zhang, Jinhua Yang, Xiaomin Zhang, Tangchun Wu, Longxian Cheng · 2014 · International Journal of Molecular Sciences
  23. Brain interleukins and Alzheimer’s disease
    Heba G. Abdelhamed, Arwa A. Hassan, Alaa Sakraan, Radwa T. Al-Deeb, Dalia M. Mousa, Heba S. Aboul Ezz, Neveen A. Noor, Yasser A. Khadrawy, Nasr M. Radwan · 2025 · Metabolic Brain Disease
  24. The Role of the IL-33/ST2 Immune Pathway in Autoimmunity: New Insights and Perspectives
    Faezeh Mashhadi Ramezani, Farhad Babaie, Saeed Aslani, Maryam Hemmatzadeh, Fatemeh Sadat Mohammadi, Arezoo Gowhari Shabgah, Farhad Jadidi‐Niaragh, Fatemeh Ezzatifar, Hamed Mohammadi · 2021 · Immunological Investigations
  25. IL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases
    Zexi Jia, Mengtian Guo, Xintong Ge, Fanglian Chen, Ping Lei · 2023 · Biomolecules
  26. Methylation Profiles of IL33 and CCL26 in Bronchial Epithelial Cells are Associated with Asthma
    Miriam Larouche, Valérie Gagné‐Ouellet, Anne‐Marie Boucher‐Lafleur, Marie-Chantal Larose, Sophie Plante, Anne‐Marie Madore, Michel Laviolette, Nicolas Flamand, Jamila Chakir, Catherine Laprise · 2018 · Epigenomics
  27. An Aging-Related Single-Nucleotide Polymorphism is Associated With Altered Clinical Outcomes and Distinct Inflammatory Profiles in Aged Blunt Trauma Patients
    Ashley J. Lamparello, Rami A. Namas, Lukas Schimunek, Maria Cohen, Fayten El-Dehaibi, Jinling Yin, Derek A. Barclay, Rubén Zamora, Timothy R. Billiar, Yoram Vodovotz B · 2019 · Shock
  28. The Role of Astrocytes in Synaptic Dysfunction and Memory Deficits in Alzheimer’s Disease
    Cristina A. Muñoz de León-López, Irene Navarro‐Lobato, Zafar U. Khan · 2025 · Biomolecules
  29. IL-33/ST2 axis promotes remodeling of the extracellular matrix and drives protective microglial responses in the mouse model of perioperative neurocognitive disorders
    Shu-Ming Li, Huan Liu, Yue Qian, Linhao Jiang, Shuai Liu, Yanling Liu, Cihang Liu, Xiaoping Gu · 2022 · International Immunopharmacology
  30. KIAA1462, A Coronary Artery Disease Associated Gene, Is a Candidate Gene for Late Onset Alzheimer Disease in APOE Carriers
    Deborah G. Murdock, Yuki Bradford, Nathalie C. Schnetz‐Boutaud, Ping Mayo, Melissa J. Allen, Laura N. D’Aoust, Xueying Sharon Liang, Sabrina L. Mitchell, Stephan L. Zuchner, Gary W. Small et al. · 2013 · PLoS ONE
  31. Ação da IL33 na artrite reumatoide: contribuição para a fisiopatalogia
    Rafaela Bicalho Viana Macedo, Adriana María Kakehasi, Marcus Vinícius Melo de Andrade · 2016 · Revista Brasileira de Reumatologia
  32. Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease
    Nilüfer Ertekin‐Taner, Philip L. De Jager, Lei Yu, David Alan Bennett · 2013 · Current Genetic Medicine Reports
  33. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition
    Yi Jayne Tan, Isabel Siow, Seyed Ehsan Saffari, Simon K. S. Ting, Li Zeng, Nagaendran Kandiah, Louis C.S. Tan, Eng‐King Tan, Adeline Su Lyn Ng · 2023 · Journal of Alzheimer s Disease
  34. Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-β precursor protein
    Julien Chapuis, Valérie Vingtdeux, Fabien Campagne, Peter Davies, Philippe Marambaud · 2011 · Human Molecular Genetics
  35. Unravelling the therapeutic potential of IL-33 for atrophic AMD
    Alison J. Clare, Jian Liu, David A. Copland, Sofia Theodoropoulou, Andrew D. Dick · 2021 · Eye
  36. Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant
    Anna Latiano, Orazio Palmieri, Fabrizio Bossa, Tiziana Latiano, Giuseppe Corritore, Ermelinda De Santo, Giuseppina Martino, Antonio Merla, Maria Rosa Valvano, Antonello Cuttitta et al. · 2014 · Human Immunology
  37. IL-33/ST2 signaling pathway and Alzheimer's disease: A systematic review and meta-analysis
    Taotao Jiang, Ting Zheng, Wenhao Li, Ning Liu, Manxia Wang · 2023 · Clinical Neurology and Neurosurgery
  38. Linkage to 20p13 including the ANGPT4 gene in families with mixed Alzheimer's disease and vascular dementia
    Anna Sillén, Jesper Brohede, Lena Lilius, Charlotte Forsell, Jorge Andrade, Jacob Odeberg, Hayao Ebise, Bengt G. Winblad, Caroline Graff · 2010 · Journal of Human Genetics
  39. The role of innate lymphoid cells (ILCs) in mental health
    Tatiana Barichello · 2022 · Discover Mental Health
  40. Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis
    Abhirami Kannan Iyer, Kathryn J. Jones, Virginia M. Sanders, Chandler L. Walker · 2018 · International Journal of Molecular Sciences
  41. The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels
    Mark Barbour, Rachel Wood, Shehla Unaiza Hridi, Chelsey Wilson, Grant McKay, Trevor John Bushell, Hui‐Rong Jiang · 2018 · Journal of Neuroimmunology
  42. Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
    Xin Zhong, Ming-Yan Liu, Miao He, Ke Du, Minjie Wei · 2017 · Neuropsychiatric Disease and Treatment
  43. IL-33 Alleviates Postoperative Cognitive Impairment by Inhibiting Hippocampal Inflammation and Upregulating Excitatory Synaptic Number in Aged Mice
    Qi Li, Yuqian Zhao, Chuanchuan Shi, Xuemin Song · 2022 · Brain Sciences
  44. IL-33/ST2 Signaling Regulates Synaptic Plasticity and Homeostasis in the Adult Hippocampal Circuitry
    Ye Wang, Amy K.Y. Fu, Nancy Y. Ip · 2021 · DNA and Cell Biology
  45. A review of the roles of keratinocyte‐derived cytokines and chemokines in the pathogenesis of atopic dermatitis in humans and dogs
    Ryota Asahina, Sadatoshi Maeda · 2017
  46. Potential associations between immune signaling genes, deactivated microglia, and oligodendrocytes and cortical gray matter loss in patients with long-term remitted cushing’s disease
    Bauduin, S.E.E.C., den Rooijen, I.L.B., Meijer, M., van der Werff, S.J.A., Keo, A., Dzyubachyk, O., Pereira, A.M., Giltay, E.J., van der Wee, N.J.A., Meijer, O.C. et al. · 2021 · Psychoneuroendocrinology
  47. Association of IL33/ST2 signal pathway gene polymorphisms with myocardial infarction in a Chinese Han population
    Jinhua Yang, Fangqin Wu, Qiang Wen, Wencai Zhang, Yange Wang, Xin Xiong, Yanwen Su, Longxian Cheng · 2015 · Journal of Huazhong University of Science and Technology [Medical Sciences]
  48. Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy
    Ladan Gol Mohammad Pour Afrakoti, Sanam Daneshpour Moghadam, Pezhman Hadinezhad · 2025 · Journal of Alzheimer s Disease Reports
  49. Transcriptomic Analyses of Neurotoxic Astrocytes Derived from Adult Triple Transgenic Alzheimer’s Disease Mice
    Diego B. Carvalho, Pablo Díaz‐Amarilla, Rosina Dapueto, María Daniela Santi, Pablo Duarte, Eduardo Savio, Henry Engler, Juan Andrés Abin‐Carriquiry, Florencia Arredondo · 2023 · Journal of Molecular Neuroscience
  50. Dissecting the immune response of CD4+ T cells in Alzheimer’s disease
    Miloš S. Kostić, Nikola Živković, Ana Cvetanović, Jelena Bašić, Ivana R. Stojanović · 2024 · Reviews in the Neurosciences
  51. What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?
    Izabela Monika Rozmilowska, Monika Helena Adamczyk-Sowa · 2017 · Journal of Neuroimmunology
  52. IL-33 Acts to Express Schaffer Collateral/CA1 LTP and Regulate Learning and Memory by Targeting MyD88
    Tomoyuki Nishizaki · 2017 · Neural Plasticity
  53. Bifidobacterium lactis-Derived Vesicles Attenuate Hippocampal Neuroinflammation by Targeting IL-33 to Regulate FoxO6/P53 Signaling
    Xiaoyu Du, Ming Zhang, Ran Wang, Zhaozhong Zeng, Wen Zhao, Bing Fang, Hanglian Lan, Wei‐Lian Hung, Haina Gao · 2024 · Nutrients
  54. The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer’s disease
    ChangQing Li, Xun Zhang, Yunqian Wang, Le Cheng, ChangBao Li, Xiang Yu · 2024 · Inflammopharmacology
  55. Analysis of IL-33 gene polymorphism (rs11792633 C/T) and risk of schizophrenia.
    Dor Mohammad Kordi-Tamandani, Ahmad Reza Bahrami, Raziye Sabbaghi-Ghale-No, Hanieh Soleimani, Tayebeh Baranzehi · 2016 · PubMed Central
  56. Higher interleukin-33 levels in aggressive periodontitis cases
    SujathaPai Ballambettu, AR Pradeep, Meera Purushottam, Somdatta Sen · 2019 · Journal of Indian Society of Periodontology
  57. JCAD expression and localization in human blood endothelial cells
    Manabu Shigeoka, Satomi Arimoto, Masaya Akashi · 2020 · Heliyon
  58. Interleukin-33: A Multifunctional Alarmin that Promotes Both Health and Disease
    Kazufumi Matsushita, Tomohiro Yoshimoto · 2013 · Springer eBooks
  59. Evidence for the Control of Aggrecanases by Insulin and Glucose in Alzheimer's Disease
    Sümeyya Akyol, Veli Uğurcu, Özlem Çakmak, Aynur Altuntaş, Yunus Yükselten, Ömer Akyol, Asuman Sunguroğlu, Kadir Demircan · 2014 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
  60. Role of Interleukin33 in Rejuvenation of Aged Neurons and Age-Related Dementias
    Ya‐Huan Lou · 2021 · Neuroscience Insights
  61. Is the Relationship Between Cardiovascular Disease and Alzheimer’s Disease Genetic? A Scoping Review
    Anni K. Moore, Marylyn DeRiggi Ritchie · 2024 · Genes
  62. Sera Level and Polymorphism of Interleukin-33 Gene in Iraqi Females Patients with Breast Cancer
    Asmaa M. Salih Almohaidi, Hazima Mossa Alabassi, Zainab Jalil Abdulkareem, Zainab Jalil Abdulkareem · 2021 · Ibn AL- Haitham Journal For Pure and Applied Science
  63. Global Deficiency of Alzheimer’s Disease Risk Gene Il1rap Reduces Pathological Tau in a Mouse Model of Systemic Inflammation
    Somayeh Dadras, Kiran Bhaskar · 2025 · ASN NEURO
  64. Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study
    Hao Wang, Ziji Cheng, Zixuan Xu, Min Wang, Xingyang Sun, Wenyu Liu, Jingtian Wang, Qian Yang, Tuo Zhang, Jie Song et al. · 2025 · Brain and Behavior
  65. The Crosstalk Between Protective and Detrimental Interleukin (IL)‐1 Family of Cytokines in Alzheimer's Disease
    Tingting Liu, Xiaoyu Li · 2025 · Journal of Biochemical and Molecular Toxicology
  66. ST2 levels and neurodegenerative diseases: is this a significant relation?
    Himanshu Arora, Binish Javed, L. V. Simhachalam Kutikuppala, Mayuri Chaurasia, Kaarvi Khullar, Shreevikaa Kannan, Golla Varshitha · 2024 · Annals of Medicine and Surgery
  67. Co Expression of GMFβ, IL33, CCL2 and SDF1 Genes in the Acute Stage of Toxoplasmosis in Mice Model and Relation for Neuronal Impairment
    Mehri Najafi, Razieh Amini, Amir Hossein Maghsood, Mohammad Fallah, Faeze Foroughi-Parvar · 2021 · Iranian Journal of Parasitology
  68. The role of innate lymphoid cells in the heart and cardiac inflammation
    Hee Sun Choi, Xuezhou Hou, William Bracamonte‐Baran, Nicola Laura Diny, Monica Vladut Talor, Daniela Čiháková · 2018 · The Journal of Immunology
  69. Chronic activation of astrocytic G q GPCR signaling has causal effects on visual LTP formation: implications for neurodegenerative diseases
    Elsie Moukarzel, Sharmilee Antoine, Sophie Guinoiseau, Bruna Rubino, J. Stinnakre, Cendra Agulhon · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Distribution of IL-33 genetic variants and circulating IL-33 levels in patients with multiple sclerosis: associations with clinical parameters in a Lithuanian population study
    Kristė Kaikarytė, Alvita Vilkevičiūtė, Renata Balnytė, Ingrida Ulozienė, Rasa Liutkevičienė · 2026 · Multiple Sclerosis and Related Disorders
  71. The Role of the IL‐33/ST2 Axis in Nervous System Development and Diseases
    Zhoutong Luo, Junhua Yang · 2026 · Immunology and Cell Biology
  72. Comparison of the interleukin-33 among the healthy and aggressive periodontitis cases
    Fozia Sultana, Annavarapu Sahithi, Anas Abdul Khader, Yella Ramya, Kommuri Kavya Reddy, A Kiranamye · 2022 · International Journal of Health Sciences
  73. pwrBRIDGE: a user-friendly web application for power and sample size estimation in batch-confounded microarray studies with dependent samples
    Qing Xia, Jeffrey A. Thompson, Devin C. Koestler · 2022 · Statistical Applications in Genetics and Molecular Biology
  74. A new mathematical modeling for pure parsimony haplotyping problem
    Reza Feizabadi, Mehri Bagherian, Hamidreza Vaziri, Maziar Salahi · 2016 · Mathematical Biosciences
  75. Biomarkers of Alzheimer Disease
    Torres,Karen Cecília de Lima, Santos,Rodrigo Ribeiro dos, Mapa,Filipe Camilo, Moraes,Flávia Lanna de, Moraes,Edgar Nunes de, Silva,Marco Aurélio Romano · 2013 · CONTINUUM Lifelong Learning in Neurology
  76. Epigenetics in mental and neurodegenerative disorders
    Iatrou · 2018
  77. PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro
    Litao Shao, Jiehong Qiu, David Y.B. Deng · 2022 · Research Square
  78. Genetics of Sporadic Cerebral Amyloid Angiopathy
    Kristiina Rannikmäe, Cathie L. M. Sudlow · 2014 · InTech eBooks
  79. Identification de déterminants génétiques impliqués dans la composante vasculaire de la MA, par analyses transcriptomiques, génétiques et moléculaires
    Julien Chapuis · 2008 · HAL
  80. Mechanisms of palmitate induced amyloidogenesis in Alzheimer's Disease mediated by astrocytes
    Li Liu · 2013
  81. Estudo do papel do eixo IL-33/ST2 na progressão da lesão periapical experimental
    Letícia Andreotti Bignardi · 2014
  82. Interleukin 33 Initiates CNS Inflammation Following Traumatic Injury
    Sachin P. Gadani · 2016
  83. ASSOCIATION BETWEEN THE MAGNITUDE OF THE IMMUNE RESPONSE AND RECURRENT MAJOR DEPRESSION DISORDER IN HUMANS AND DEPRESSION-LIKE BEHAVIOR IN ANIMALS
    Anastacia Y. Kudinova · 2018 · The Open Repository - Binghamton (Binghamton University)
  84. Role of IL-33/ST2 Axis in Chronic Inflammatory Neurological Disorderss
    Jelena Dimitrijević, Aleksandar Arsenijević, Marija Milovanović, Bojana Stojanović, Dragana Arsenijević, Jelena Milovanović, Nebojša Arsenijević · 2021 · Serbian Journal of Experimental and Clinical Research
  85. Gene Therapy
    Magisetty Obulesu · 2019 · Elsevier eBooks
  86. Interleukin33-NFκB Axis Mediated DNA Damage Repair in Neurons: Does Its deficiency Initiate a Path toward Late-Onset Alzheimer’s Disease?
    Ya‐Huan Lou · 2022 · American Journal of Biomedical Science & Research
  87. Neuron-Glia Crosstalk: Investigating Immune-Cell Modulation in the CNP1 Null Mutant Mouse
    Marie Louise Aicher · 2023
  88. Epigenome-wide profiling in the dorsal raphe nucleus highlights cell-type-specific changes in TNXB in Alzheimer’s disease
    Renzo J. M. Riemens, Ehsan Pishva, Artemis Iatrou, Janou A. Y. Roubroeks, Jennifer Nolz, Roy Lardenoije, Mourad W. Ali, Antonio del Sol, Raúl Delgado‐Morales, Manel Esteller et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  89. PLEACH: a new heuristic algorithm for pure parsimony haplotyping problem
    Reza Feizabadi, Mehri Bagherian, Hamidreza Vaziri, Maziar Salahi · 2023 · The Journal of Supercomputing
  90. Expression profile of miR-214, miR-204, miR-25, miR-15a, IL-33, and plasma level of Malondialdehyde might serve as potential biomarkers for Alzheimer’s disease
    Haydar Sahib Almawashee, Mohammad Khalaj‐Kondori, Mohammad Ali Hoseinpour Feizi, Reza Safaralizadeh · 2024 · Research Square
  91. In vivo and in vitro assays, and safety profiles of cannabinoids
    Mayeso N.V. Gwedela, Collins Edward Jana, Tuntufye Mwambyale, Ibrahim Chikowe, Lifa Chimphepo, George Chirambo · 2024 · Elsevier eBooks
  92. Brain Innate Immune System and Its Modulation by Diet: The Role of Polyunsaturated Fatty Acids
    Sophie Layé, Anaïs M. Duffaud · 2010 · Humana Press eBooks
  93. Additional file 2 of Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease
    Ceren Emre, V. Khanh, Bokkyoo Jun, Erik Hjorth, Alcalde, Silvia Gómez, Kautzmann, Marie-Audrey I., William C. Gordon, Per Nilsson, Bazan, Nicolas G., Marianne Schultzberg · 2021 · Figshare
  94. Additional file 1 of Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease
    Ceren Emre, V. Khanh, Bokkyoo Jun, Erik Hjorth, Alcalde, Silvia Gómez, Kautzmann, Marie-Audrey I., William C. Gordon, Nilsson, Per, Bazan, Nicolas G., Marianne Schultzberg · 2021 · Figshare
  95. Additional file 5 of Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease
    Ceren Emre, V. Khanh, Bokkyoo Jun, Erik Hjorth, Alcalde, Silvia Gómez, Kautzmann, Marie-Audrey I., William C. Gordon, Per Nilsson, Bazan, Nicolas G., Marianne Schultzberg · 2021 · Figshare
  96. Additional file 3 of Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease
    Ceren Emre, V. Khanh, Bokkyoo Jun, Erik Hjorth, Alcalde, Silvia Gómez, Kautzmann, Marie-Audrey I., William C. Gordon, Per Nilsson, Bazán Ng, Marianne Schultzberg · 2021 · Figshare
  97. The IL-33/ST2 Axis Protects the Hippocampus from LPS-Induced Inflammation and Damage by Modulating Microglial Phenotype
    Jelena Nedeljkovic, Jelena Milovanović, Vladimir Markovic, Natalia Solovjova, Sara S. Mijailovic, Nebojsa D. Zdravkovic, Nikola Nedeljkovic, Marija Milovanovic · 2026 · Biomedicines
  98. Central nervous system pericytes express soluble ST2 in inflammation and injury
    Deidre Jansson, Blake Highet, Susan Li, Taylor J. Stevenson, Leon C. D. Smyth, Justin Rustenhoven, Sheryl Xia Feng, Richard Daneman, Cayce Dorrier, Andrew N. Clarkson et al. · 2026 · Molecular Brain
  99. Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
    Geoffroy O. Laumet · 2010 · theses.fr (ABES)
  100. Role of astrocytic calcium signaling in synaptic transmission, plasticity and memory : implications for neurodegenerative diseases
    Elsie Moukarzel · 2021 · theses.fr (ABES)